Yes working now. Had been trying since last 2 days. Opened only now. Thanks.
Posts tagged Value Pickr
BSE (Bombay Stock Exchange)- Bet on Financialization? (03-07-2024)
If this happens how much it can impact on the BSE business? Any views? If only 10% traders make profits it will discourage them also due to higher taxation. Can it affect the long term prospects of BSE.
Disc : Invested
Phantom Digital Effects Limited (03-07-2024)
Updates from Company Linked in posts since Last week:
Company has recently posted on LinkedIn that their involvement in “Kalki 2898 AD” movie and “Indian 2”.
Disclaimer: But majority of work for Kalki movie was done from DNEG a London based company.
Indian 2 has very less Visual effect as compared to movie Kalki.
Also I can see lot of Job posts in their company profile, Which could mean company is again looking at expansion.
Ranvir’s Portfolio (03-07-2024)
Marico -
Q4 and FY 24 results and concall highlights -
Q4 outcomes -
Revenues - 2278 vs 2240 cr, up 2 pc
EBITDA - 442 vs 393 cr, up 12 pc ( margins @ 19 vs 18 pc )
PAT - 320 vs 305 cr
Domestic volume growth @ 3 pc. International constant currency growth @ 10 pc
FY 24 outcomes -
Revenues - 9653 vs 9764 cr
EBITDA - 2026 vs 1810 cr ( margins @ 21 vs 19 pc - highest ever )
PAT - 1481 vs 1302 cr, up 14 pc
Parachute franchise reported a volume growth of 2 pc in FY 24
Saffola Oils grew volumes in mid-single digits. However, the value decline was 16 pc due steep fall in prices
Value Added Hair Oils ( VAHO ) reported a 7 pc value de-growth in FY 24
Premium personal care products like - Livon, SetWet clocked 300 cr revenue run rate in Q4
Digital first brands like - Beardo, CocoSoul, Just Herbs - clocked 450 cr revenue run rate in Q4
Foods portfolio ( led by Saffola branded - Oats, Munchiez, Honey, Soya Chunks, Peanut Butter , PLIX branded products etc ) grew by 24 pc in Q4 with a massive 8 pc gross margin expansion
Company aims to double the size of foods portfolio and Digital first brands in next 3 yrs along with further margin expansion
Current revenue share of foods business in the company is @ 15 pc. Aim to take it to 25 pc by end of FY 27
Current revenue share of Bangladesh in the international business is 44 pc. Aim to bring it down to 40 pc by end of FY 27
Company has rolled out project Setu wef Q1 FY 25 - laying a 3 yr roadmap to improve their direct reach from 10 lakh outlets to 15 lakh outlets
Scouting for inorganic opportunities to accelerate company level growth
Rural growth showing visible uptick in Q4
Have increased prices by 6 pc across the Parachute portfolio due increasing copra prices
Expect domestic revenue growth to be greater than volume growth wef Q1 FY 25
Expecting the Bangladesh business to grow in double digits in FY 25
The price cuts in Saffola Edible Oils will anniversarize towards the end of Q1
Have seen hyper competition in the economy segment in Value added hair oils in FY 24. Company hopes that such high intensity should abate in FY 25
Company hopes to further improve its margins over next 3-4 yrs driven by - further scale up of digital brands, higher share of revenues from higher gross margin products and kicking in of operational leverage in Online and International business
It is extremely important for company to expand its direct reach in order to grow their newer / challenger brands. Traditional distributor led models only focus on those SKUs / Brands that are fast moving. Therefore, its imperative for the company to keep expanding its direct distribution reach to give oxygen to new product introductions
Disc: not holding, not SEBI registered, posting for learning purposes
Persistent Systems-Potential Multibagger (03-07-2024)
This is not so good area to invest they also paid 3 times sales for a stagnant business , why again start investing in product businesses but overall this acquisition has no significance
Yatharth Hospital & Trauma Care Services Limited (03-07-2024)
If everything was perfect, it wouldn’t be trading at ~24x FY25E PE (likely FY25 consol PAT to be around 150 crs in my view)
-
There are issues ofcourse. I do expect the receivable issue to get sorted in next 2 months - the trigger isn’t just elections but also reducing fiscal deficit of GoI and transmission of funds as a way to spur pvt capex by GoI (been done in the past iirc)
-
Re CRISIL’s issuer not cooperating - I wouldn’t put too much of emphasis here since the company regularly hosts con call and is fairly open to being grilled. It would have been very different had they not published investor presentation or hosted con calls.
Disclosure - Had exited post Q4 when I discovered that 70-80 crs was frozen by Income Tax and they never disclosed. Entered yesterday at around 415 since the risk reward seems favorable on a 1 year basis.
Sumitomo Chemicals ~ After Excel Crop Care Acquisition (03-07-2024)
Have to say, not quite the done thing to go back and edit an earlier post after we have exchanged messages subsequently. It’s ok if you don’t want to share and have a different opinion, but let’s be transparent here.
I am referring to this edit - “And ,also humbly speaking, I would not like to be discuss further about this company. For me it is cyclical generic company where parent is struggling and has a bad track record of last 1-2 decades. Hence would like to stay away as don’t want to waste more time on this.”
All E Technologies, making businesses ready for AI (03-07-2024)
Thank you @aadhar.aggarwal for the detailed write up to start this thread. This company showed up on one of my screeners and seems to be be quite an interesting business. They have a consulting approach in regard to their clients needs. From the latest con-call the management has guided for 25% organic growth and even provided a ‘North Star’ sort of revenue target of 1000cr that they hope to achieve in the future. They also clarified that they are not averse to partnering with other tech giants, it just so happens that Microsoft products are best in class right now with adoption growing faster than the market. Their own product could be a growth trigger in the future as well as any inorganic growth by way of acquisition.